Deaths and drug citations
Vaccine death citations  Drug adverse reactions citations

Gatnash AA, Connolly CK.Fatal chickenpox pneumonia in an asthmatic patient on oral steroids and methotrexate.Thorax. 1995 Apr;50(4):422-3.PMID: 7785019; UI: 95304500
Kasper WJ, Howe PM.Fatal varicella after a single course of corticosteroids.Pediatr Infect Dis J. 1990 Oct;9(10):729-32. No abstract available.PMID: 2235146; UI: 91044642
Lantner R, Rockoff JB, DeMasi J, Boran-Ragotzy R, Middleton E Jr.Fatal varicella in a corticosteroid-dependent asthmatic receiving troleandomycin.Allergy Proc. 1990 Mar-Apr;11(2):83-7.PMID: 2338242; UI: 90249721
Lake KB, Browne PM, Van Dyke JJ, Ayers L.Fatal disseminated aspergillosis in an asthmatic patient treated with corticosteroids.Chest. 1983 Jan;83(1):138-9. No abstract available.PMID: 6848318; UI: 83078373
Mallet L, Mallet J. Ticlopidine and fatal aplastic anemia in an elderly woman.Ann Pharmacother. 1994 Oct;28(10):1169-71.PMID: 7841572; UI: 95143709
Omdal R, Goransson L, Bergrem H.Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis.Clin Rheumatol. 1993 Jun;12(2):283-4. No abstract available.PMID: 8358998 [PubMed - indexed for MEDLINE]
Morice AH, Lai WK.Fatal varicella zoster infection in a severe steroid dependent asthmatic patient receiving methotrexate.Thorax. 1995 Nov;50(11):1221-2.PMID: 8553283; UI: 96149331
No authors listed]Varicella-related deaths among adults--United States, 1997.MMWR Morb Mortal Wkly Rep. 1997 May 16;46(19):409-12.PMID: 9162840; UI: 97299946http://www.cdc.gov/mmwr/preview/mmwrhtml/00047618.htm
Riley LC, et al Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council Acute Myeloid Leukaemia Trial (MRC AML10). Br J Haematol. 1999 Aug;106(2):436-444. [Record as supplied by publisher] PMID: 10460604.
Between 1988 and 1995, 341 children with acute myeloid leukaemia (AML) were treated on the Medical Research Council Acute Myeloid Leukaemia Trial (MRC AML10). The 5-year overall survival was 57%, much improved on previous trials. However, there were 47 deaths (13.8%), 11 of which were associated with bone marrow transplantation (BMT). The treatment-related mortality was significant at 13.8%, but decreased in the latter half of the trial from 17.8% in 1998-91 to 9.6% in 1992-95 (P = 0.03%). The main causes of death were infection (65.9%), haemorrhage (19.1%) and cardiac failure (19.1%). Fungal infection was a significant problem, causing 23% of all infective deaths. Haemorrhage occurred early in treatment, in children with initial white cell counts >100 x 109/l (P = 0.001), and was more common in those with M4 and M5 morphology. Cardiac failure only occurred from the third course of chemotherapy onwards, with 78% (7/9) in conjunction with sepsis as a terminal event. Some deaths could be prevented by identifying those most at risk, and with prompt recognition and aggressive management of complications of treatment. Future options include the prophylactic use of antifungal agents, and the use of cardioprotectants or alternatives to conventional anthracyclines to decrease cardiac toxicity. PMID: 10460604
Silk HJ, Guay-Woodford L, Perez-Atayde AR, Geha RS, Broff MD.Fatal varicella in steroid-dependent asthma.J Allergy Clin Immunol. 1988 Jan;81(1):47-51.PMID: 3339190; UI: 88116368
Sy ML, Chin TW, Nussbaum E.Pneumocystis carinii pneumonia associated with inhaled corticosteroids in an immunocompetent child with asthma.J Pediatr. 1995 Dec;127(6):1000-2. No abstract available.PMID: 8523172; UI: 96101729
Wolfromm R, Herman D.Fatal varicella in a corticosteroid-dependent asthmatic receiving troleandomycin.Allergy Proc. 1990 Mar-Apr;11(2):83-7.PMID: 2338242; UI: 90249721